Quest Diagnostics 2024 Corporate Responsibility Report

Quest Diagnostics is dedicated to improving health outcomes and transforming lives through its diagnostic services. This report outlines the company's commitment to corporate responsibility, focusing on key areas that drive business value and positively impact patients and communities.

Our Purpose and Strategy

Quest Diagnostics operates with a clear set of principles known as 'The Quest Way,' encompassing Purpose, Strategy, and Culture. Their purpose is to work together to create a healthier world, one life at a time. The strategy involves providing innovative, convenient, and affordable solutions that meet evolving customer needs, achieved through an industry-leading testing menu, strategic collaborations, data utilization, and technological advancements.

Key Focus Areas

  • Health Access: Expanding access to diagnostic tests, supporting community health initiatives, and improving patient financial assistance programs.
  • Patient and Consumer-Centered Care: Enhancing the patient experience at all touchpoints, particularly in Patient Service Centers (PSCs), and introducing innovations to meet specific patient needs.
  • Employee and Community Engagement: Fostering a safe, valued, and challenging environment for employees, and supporting communities through philanthropy and volunteerism.
  • Governance and Ethics: Maintaining strong ethical governance and responsible business practices, adhering to laws and regulations, and actively engaging with stakeholders.
  • Environmental Sustainability: Minimizing the environmental impact of operations through initiatives like electric vehicle adoption, waste reduction, and pursuing ISO 14001 certification.

2024 Highlights

In 2024, Quest Diagnostics achieved significant milestones:

  • Reach: Processed approximately 217 million test requisitions, serving around 600,000 patients daily through 2,400 Patient Service Centers.
  • Innovation: Developed approximately 50 new tests, including advancements in Alzheimer's disease diagnostics and type 1 diabetes medication monitoring. Launched the first H5 avian influenza test.
  • Impact: Invested approximately $13 million in corporate giving and Foundation grants, facilitated over 5,000 employee volunteer hours, and donated over $700,000 through employee matching programs.
  • Thought Leadership: Published 3 new Health Trends® reports, presented at numerous conferences, and holds over 1,600 patents.

Quest Diagnostics Foundation

The Quest Diagnostics Foundation plays a crucial role in addressing social drivers of health, improving access to testing, screening, and diagnosis in communities across the US. With a $100 million pledge made in 2020, the foundation has granted $46 million and supported over 80 initiatives, reaching 38 states plus Washington D.C. and Puerto Rico.

Global Expansion

Quest Diagnostics expanded its services in Canada through the acquisition of LifeLabs, a leading provider of laboratory diagnostic information, enhancing access to advanced diagnostics and customer service across Canada.

PDF preview unavailable. Download the PDF instead.

Quest-Diagnostics-Corporate-Responsibility-Report-2024 Adobe InDesign 20.4 (Macintosh) Adobe PDF Library 17.0

Related Documents

Preview New York Clinical Laboratory Permit - Quest Diagnostics Nichols Institute of Valencia Inc
Official New York State Department of Health Clinical Laboratory Permit issued to Quest Diagnostics Nichols Institute of Valencia Inc, detailing authorized laboratory procedures and validity dates.
Preview Quest Diagnostics Autoimmune Screening: Faster Diagnosis and Care Guide
A guide from Quest Diagnostics for primary care providers on understanding autoimmune screening results, including ANA and disease-specific biomarkers. Learn how comprehensive testing aids in faster differential diagnosis and improved patient outcomes.
Preview Quest Diagnostics Genetic Insights: Hereditary Hemochromatosis Quick Reference Guide for Healthcare Providers
A quick reference guide from Quest Diagnostics for healthcare providers on interpreting Genetic Insights test results for Hereditary Hemochromatosis, covering key findings, next steps, management options, and patient conversation starters.
Preview Quest Diagnostics Drug Testing Index: Industry Positivity Rates 2020-2024
Quest Diagnostics report detailing workforce drug testing positivity rates across various industries in the U.S. from 2020 to 2024, including data for marijuana, cocaine, opiates, amphetamines, and methamphetamine.
Preview Quest Diagnostics Genetic Counseling Resources for Patients
A guide to genetic counseling resources provided by Quest Diagnostics, listing companies offering genetic counseling services via phone and videoconference, along with their specialties and contact information.
Preview Genetic Insights: SMAD4 Variant for JPS/HHT - Healthcare Provider Guide
A quick reference guide for healthcare providers on interpreting Genetic Insights test results for Juvenile Polyposis Syndrome (JPS) and Hereditary Hemorrhagic Telangiectasia (HHT) associated with the SMAD4 gene, including key results, next steps, and patient conversation starters.
Preview Quantisal™ Oral Fluid Sample Collection and Shipping Instructions
Comprehensive guide for patients on collecting oral fluid samples using the Quantisal™ device for physician-ordered tests, covering self-collection preparation, step-by-step procedures, and packing/shipping instructions.
Preview Developing a Business Proposal for Enterprise Content Management
A white paper on how to demonstrate the value of an enterprise content management system (ECM) by developing a business proposal. It covers identifying challenges, gaining stakeholder support, analyzing costs and risks, calculating ROI, and delivering the proposal.